Sanofi
Close on Nov 19, 2026Market cap $112.33BP/E 13.1Yield –
Sanofi Completed Clinical Trials with Publicly Shared Results by Year
Completed Clinical Trials with Publicly Shared Results & Anonymized Data
Sanofi Completed Clinical Trials with Publicly Shared Results: 260 in FY2025, up 10.6% from a year earlier.
Where the FY2025 figure comes from
Source: Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗
Reported in Sanofi CSRD / ESG Key Performance Indicators Workbook.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Completed Clinical Trials with Publicly Shared Results & Anonymized Data | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 260 | +10.6% | Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗ |
| FY2024 | Dec 31, 2024 | 235 | +15.2% | Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗ |
| FY2023 | Dec 31, 2023 | 204 | – | Sanofi 2025 ESG Key Performance Indicators Databook (CSRD / ESRS) ↗ |
Cite this data
StockData. (2026). Sanofi Completed Clinical Trials with Publicly Shared Results, annual FY2023–FY2025 [Data set]. Compiled from Sanofi SEC filings and investor materials. https://stockdatahq.com/stocks/sny/kpis/esg-ct-shared-data
See every metric in the Sanofi KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?